PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Jun-2023 Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances Spexis AG
07-Jun-2023 STRATEC SE: STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS STRATEC SE
06-Jun-2023 OKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease OKYO Pharma
06-Jun-2023 Canton of Geneva supports Connect in Pharma 2023 The Canton of Geneva
06-Jun-2023 ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023 ELRIG UK
06-Jun-2023 Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly Amolyt Pharma
06-Jun-2023 BIAL announces positive results from phase 3 study in early levodopa treated Parkinson’s disease patients without motor complications BIAL
06-Jun-2023 Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care AstraZeneca
06-Jun-2023 Anticounterfeiting in the spotlight as MM Packaging sponsors PHARMAP 2023 roundtable MM Packaging
06-Jun-2023 KRW BioReg Solutions Ltd and Applied Biopharm Consulting Announce Strategic Partnership KRW BioReg Solutions Ltd / Applied Biopharm Consulting
06-Jun-2023 The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares Moberg Pharma AB
06-Jun-2023 Canton of Geneva supports Connect in Pharma 2023 Sciad Newswire
06-Jun-2023 MPH Health Care AG: Q1 result 2023 MPH Health Care AG
06-Jun-2023 T-CURX GmbH Announces Senior Leadership Appointments to Significantly Bolster Clinical Team B3C newswire
06-Jun-2023 Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER Defence Therapeutics Inc.
05-Jun-2023 Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi Secarna Pharmaceuticals GmbH & Co. KG
05-Jun-2023 Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June Biophytis
05-Jun-2023 Evotec presents sustainability strategy Evotec SE
02-Jun-2023 Cannovum Cannabis AG: Annual financial statements 2022 and issuance of further convertible bonds  Cannovum Cannabis AG
02-Jun-2023 Resolutions from Aqilion Annual General Meeting 2023 AQILION AB